Sacubitril/valsartan affects pulmonary arterial pressure in heart failure with preserved ejection fraction and pulmonary hypertension

AIMS: Prior studies have not fully characterized the haemodynamic effects of the angiotensin receptor‐neprilysin inhibitor (ARNI) sacubitril/valsartan in heart failure with preserved ejection fraction and pulmonary hypertension (HFpEF–PH). The aim of the Treatment of PH With Angiotensin II Receptor...

Descripción completa

Detalles Bibliográficos
Autores principales: Codina, Pau, Domingo, Mar, Barceló, Elena, Gastelurrutia, Paloma, Casquete, Daniel, Vila, Joan, Abdul‐Jawad Altisent, Omar, Spitaleri, Giosafat, Cediel, Germán, Santiago‐Vacas, Evelyn, Zamora, Elisabet, Ruiz‐Cueto, María, Santesmases, Javier, de la Espriella, Rafael, Pascual‐Figal, Domingo A., Nuñez, Julio, Lupón, Josep, Bayes‐Genis, Antoni
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9288803/
https://www.ncbi.nlm.nih.gov/pubmed/35588235
http://dx.doi.org/10.1002/ehf2.13952

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9288803/
https://www.ncbi.nlm.nih.gov/pubmed/35588235
http://dx.doi.org/10.1002/ehf2.13952

Ejemplares similares